Valuation: Medinotec Inc.

Market Cap 58.67M 51.27M 47.31M 43.61M 82.19M 5.65B 84.02M 565M 222M 2.77B 220M 215M 9.53B P/E 2025
27.2x
P/E 2026 74x
Enterprise Value 55.93M 48.87M 45.1M 41.57M 78.35M 5.39B 80.09M 539M 212M 2.64B 210M 205M 9.08B EV / Sales 2025
6,241,228x
EV / Sales 2026 5,748,224x
Free-Float
15.57%
Yield 2025 *
-
Yield 2026 -
3 years 5
Extreme 5
5
5 years 5
Extreme 5
5
10 years 5
Extreme 5
5
Manager TitleAgeSince
Chief Executive Officer 47 2021-04-25
Director of Finance/CFO 40 2021-04-25
Director TitleAgeSince
Director/Board Member 69 2022-06-12
Director/Board Member 55 2022-06-12
Director/Board Member 40 2021-04-25
Date Insider Type Main position Quantity % Market Cap.
4/16/25 Other

Chief Executive Officer

4,750,179 40.4830%
4/16/25 Other

Director

12,073 0.1029%
4/16/25 Other

Chief Financial Officer

401,965 3.4257%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-.--%-.--% 58.67M
-3.42%-3.01%-17.86%+8.62% 123B
-1.39%-1.56%+0.71%-5.21% 13.03B
+0.93%+2.69%+60.52%+102.65% 9.21B
+3.09%+12.41%-43.39%-68.01% 4.47B
-6.27%-0.13%+5.35%+45.60% 2.7B
-6.41%-7.36%-22.63%-31.21% 1.62B
-4.80%-0.43%-12.90%-21.68% 1.6B
-3.56%+5.13%+2.97%-58.47% 1.56B
Average -2.43%+2.02%-3.03%-3.08% 17.43B
Weighted average by Cap. -2.90%-1.66%-11.83%+10.05%

Financials

2025 2026
Net sales 9.11 7.96 7.35 6.77 12.77 877.65 13.05 87.84 34.55 429.84 34.23 33.48 1.48K 9.73 8.5 7.85 7.23 13.63 936.96 13.93 93.78 36.89 458.89 36.54 35.74 1.58K
Net income 2.16M 1.89M 1.74M 1.61M 3.03M 208M 3.09M 20.81M 8.19M 102M 8.11M 7.93M 351M 795K 694K 641K 591K 1.11M 76.51M 1.14M 7.66M 3.01M 37.47M 2.98M 2.92M 129M
Net Debt -1.79M -1.56M -1.44M -1.33M -2.51M -172M -2.56M -17.24M -6.78M -84.36M -6.72M -6.57M -290M -2.74M -2.4M -2.21M -2.04M -3.84M -264M -3.93M -26.43M -10.39M -129M -10.3M -10.07M -445M
Logo Medinotec Inc.
Medinotec Inc., through its primary investment in DISA Medinotec Proprietary Limited, is engaged in medical device manufacturing and distribution. The Company’s segments include Sales Outside the United States and Domestic Sales. The Sales Outside the United States segment includes both internally developed products and third-party products distributed under agreement. The Domestic Sales segment focuses on the proprietary Trachealator product within the United States. The Company manufactures and distributes medical devices that focus on tracheal non-occlusive airway dilatation technology. Its products include Trachealator, Cape Cross PTCA Catheter, Cape Cross Non-Compliant Catheter, Aortic Valve Dilatation Balloon Catheter, and Micro CTO Catheter. The products developed are sold through a network of distributors in many parts of the world and through a direct sales force in South Africa and the United States of America.
Employees
36
  1. Stock Market
  2. Stocks
  3. MDNC Stock